Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel (STRONG STAR)
Primary Purpose
Posttraumatic Stress Disorders, Combat Disorders
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prolonged Exposure Therapy - Massed
Prolonged Exposure Therapy - Spaced
Minimal Contact Control
Present-Centered Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Posttraumatic Stress Disorders focused on measuring Military, Combat, Psychological Treatment, Psychotherapy, Trauma, Posttraumatic Stress, Posttraumatic Stress Disorder, PTSD, Prolonged Exposure, Exposure therapy, Behavior Therapy, Cognitive Behavior Therapy, Post-Traumatic Stress Disorders, Stress Disorders, Post-traumatic
Eligibility Criteria
Inclusion Criteria:
- Adult male and female active-duty OIF/OEF military personnel and recently separated OIF/OEF veterans ages 18-65 seeking treatment for PTSD
- Diagnosis of PTSD determined by a clinician-administered Posttraumatic Stress Scale (PSS-I).
Exclusion Criteria:
- Current bipolar disorder or other psychotic disorder (as determined by the evaluator conducting the patient interview and medical record review)
- Current alcohol dependence (as determined by the AUDIT)
- Evidence of a moderate or severe traumatic brain injury (as determined by the inability to comprehend the baseline screening questionnaires)
- Current suicidal ideation severe enough to warrant immediate attention (as determined by the Scale for Suicidal Ideation)
- Other psychiatric disorders severe enough to warrant designation as the primary disorder
Sites / Locations
- Center for the Treatment and Study of Anxiety, University of Pennsylvania
- Carl R. Darnall Army Medical Center
- University of Texas Health Science Center at San Antonio
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Other
Experimental
Active Comparator
Active Comparator
Arm Label
Minimal Contact Control
PE-Massed
PE-Spaced
Present-Centered Therapy (PCT)
Arm Description
Outcomes
Primary Outcome Measures
Change in PTSD Symptom Scale, Interview Version (PSS-I) following treatment
Affect of treatment on this measure of PTSD symptomology
Secondary Outcome Measures
PTSD Checklist-Stressor-specific version (PCL-S)
Affect of treatment on a PTSD Assessment of stress
PTSD Checklist-Stressor-specific version (PCL-S)
Changes in PTSD stress symptomology upon commencement of treatment
PTSD Checklist-Stressor-specific version (PCL-S)
Changes in PTSD stress symptomology upon commencement of treatment
PTSD Checklist-Stressor-specific version (PCL-S)
Changes in PTSD stress symptomology upon commencement of treatment
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) over course of treatment
PTSD Assessment
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
PTSD Assessment
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
PTSD Assessment
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
PTSD Assessment
Full Information
NCT ID
NCT01049516
First Posted
January 12, 2010
Last Updated
November 26, 2018
Sponsor
University of Pennsylvania
Collaborators
The University of Texas Health Science Center at San Antonio, U.S. Army Medical Research and Development Command
1. Study Identification
Unique Protocol Identification Number
NCT01049516
Brief Title
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
Acronym
STRONG STAR
Official Title
Prolonged Exposure for PTSD Among OIF/OEF Personnel: Massed vs. Spaced Trials
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
August 2018 (Actual)
Study Completion Date
August 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania
Collaborators
The University of Texas Health Science Center at San Antonio, U.S. Army Medical Research and Development Command
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is 1) to evaluate whether massing 10 PE sessions in 2 weeks (massed trials; M-PE) is more efficacious than Minimal Contact control (MCC); 2) whether the massed sessions format retains the efficacy of treatment compared to 10 PE sessions spaced over 8 weeks (spaced trials; S-PE), and 3) to evaluate for the first time the efficacy of the 10 PE sessions delivered in 8 weeks in an active duty population by comparing it to an active comparison condition, Present-Centered Therapy (PCT).
Detailed Description
The purpose of this study is to improve the efficiency of treatment for post-traumatic stress disorder (PTSD) with prolonged exposure (PE), an efficacious treatment for PTSD typically administered in once- or twice-weekly sessions. We will evaluate whether massing 10 PE sessions in 2 weeks (massed trials; M-PE) is more efficacious than Minimal Contact control (MCC); 2) whether the massed sessions format retains the efficacy of treatment compared to 10 PE sessions spaced over 8 weeks (spaced trials; S-PE), and 3) will evaluate for the first time the efficacy of the 10 PE sessions delivered in 8 weeks in an active duty population by comparing it to an active comparison condition, Present-Centered Therapy (PCT). Randomization was initially set at 3:11:11:11 for MCC:M-PE:S-PE:PCT. Due to the urgent need for data to inform military clinical practice, enrollment in MCC was accelerated by changing the ratio to 1:1:1:1 in order to report the comparison between M-PE and MCC. When 30 participants were enrolled in MCC, randomization resumed to approximately 3:11:11:11. Prolonged Exposure (PE; Foa, Hembree, & Rothbaum, 2007; Foa & Rothbaum, 1998) was developed by the PI, Edna Foa, and colleagues in the Center for the Treatment & Study of Anxiety (CTSA), University of Pennsylvania. It has been found quite efficacious in reducing PTSD and related psychopathology with various types of trauma in PTSD centers around the world. Furthermore, PE has been identified in the joint VA-Department of Defense Clinical Practice Guideline for PTSD (VA-DoD Clinical Practice Guideline Working Group, 2003) as "strongly recommended" for use with veterans with PTSD, based on the strong empirical support for PE.
This study is part of the South Texas Research Organizational Network Guiding Studies on Trauma and Resilience (STRONG STAR) (Consortium Director: Alan L. Peterson, Ph.D., ABPP, Professor, Behavioral Wellness Center for Clinical Trials, Department of Psychiatry-Mail Code 7792, University of Texas Health Science Center at San Antonio (UTHSCSA), 7703 Floyd Curl Drive, San Antonio, TX 78229-3900). Dr. Edna Foa is the overall PI of the study, and the on-site PI is COL Jeffrey Yarvis, Ph.D.,Chief, Soldier Behavioral Health/Outpatient Psychiatry, Carl R. Darnall Army Medical Center, 36000 Darnall Loop, Fort Hood, TX, 76544. The study will be conducted at Fort Hood, Texas.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Posttraumatic Stress Disorders, Combat Disorders
Keywords
Military, Combat, Psychological Treatment, Psychotherapy, Trauma, Posttraumatic Stress, Posttraumatic Stress Disorder, PTSD, Prolonged Exposure, Exposure therapy, Behavior Therapy, Cognitive Behavior Therapy, Post-Traumatic Stress Disorders, Stress Disorders, Post-traumatic
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
366 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Minimal Contact Control
Arm Type
Other
Arm Title
PE-Massed
Arm Type
Experimental
Arm Title
PE-Spaced
Arm Type
Active Comparator
Arm Title
Present-Centered Therapy (PCT)
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Prolonged Exposure Therapy - Massed
Other Intervention Name(s)
Massed-PE
Intervention Description
10 75-90 minute psychotherapy sessions, focused on gradually confronting distressing trauma-related memories and reminders. Sessions occur 5 days/week for two weeks.
Intervention Type
Behavioral
Intervention Name(s)
Prolonged Exposure Therapy - Spaced
Other Intervention Name(s)
Spaced-PE
Intervention Description
10 75-90 minute psychotherapy sessions, focused on gradually confronting distressing trauma-related memories and reminders. Sessions 1-3 occur in the first two weeks, Sessions 4-5 occur in Weeks 3-4, and Sessions 6-10 occur in Weeks 5-10.
Intervention Type
Behavioral
Intervention Name(s)
Minimal Contact Control
Other Intervention Name(s)
Wait List
Intervention Description
Participants receive minimal contact for 4 weeks after randomization and thereafter are offered PE-Spaced or PE-Massed, according to their preference. Participants receive 10-15 minute phone calls once per week by the study therapist or independent evaluator in order to monitor their status and to provide support as needed.
Intervention Type
Behavioral
Intervention Name(s)
Present-Centered Therapy
Intervention Description
10 75-90 minute psychotherapy sessions, focused on identifying and solving day-to-day problems as they are brought up by the participants
Primary Outcome Measure Information:
Title
Change in PTSD Symptom Scale, Interview Version (PSS-I) following treatment
Description
Affect of treatment on this measure of PTSD symptomology
Time Frame
Baseline to 6-month follow-up (approximately 34 weeks for Spaced PE and PCT, 26 weeks for Massed PE
Secondary Outcome Measure Information:
Title
PTSD Checklist-Stressor-specific version (PCL-S)
Description
Affect of treatment on a PTSD Assessment of stress
Time Frame
Baseline to Post-treatment (approximately 10 weeks for Spaced PE and PCT, 2 weeks for Massed PE)
Title
PTSD Checklist-Stressor-specific version (PCL-S)
Description
Changes in PTSD stress symptomology upon commencement of treatment
Time Frame
Post-treatment to 2-week follow-up
Title
PTSD Checklist-Stressor-specific version (PCL-S)
Description
Changes in PTSD stress symptomology upon commencement of treatment
Time Frame
2-week follow-up to 12-week follow-up
Title
PTSD Checklist-Stressor-specific version (PCL-S)
Description
Changes in PTSD stress symptomology upon commencement of treatment
Time Frame
12-week follow-up to 6-month follow-up
Title
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) over course of treatment
Description
PTSD Assessment
Time Frame
Baseline to Post-treatment (approximately 10 weeks for Spaced PE and PCT, 2 weeks for Massed PE)
Title
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
Description
PTSD Assessment
Time Frame
Post-treatment to 2-week follow-up
Title
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
Description
PTSD Assessment
Time Frame
2-week follow-up to 12-week follow-up
Title
Changes in PTSD diagnosis using PTSD Symptom Scale, Interview Version (PSS-I) following treatment
Description
PTSD Assessment
Time Frame
12-week follow-up to 6-month follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult male and female active-duty OIF/OEF military personnel and recently separated OIF/OEF veterans ages 18-65 seeking treatment for PTSD
Diagnosis of PTSD determined by a clinician-administered Posttraumatic Stress Scale (PSS-I).
Exclusion Criteria:
Current bipolar disorder or other psychotic disorder (as determined by the evaluator conducting the patient interview and medical record review)
Current alcohol dependence (as determined by the AUDIT)
Evidence of a moderate or severe traumatic brain injury (as determined by the inability to comprehend the baseline screening questionnaires)
Current suicidal ideation severe enough to warrant immediate attention (as determined by the Scale for Suicidal Ideation)
Other psychiatric disorders severe enough to warrant designation as the primary disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edna B. Foa, Ph.D.
Organizational Affiliation
Center for the Treatment and Study of Anxiety, University of Pennsylvania
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Elna Yadin, Ph.D.
Organizational Affiliation
Center for the Treatment and Study of Anxiety, University of Pennsylvania
Official's Role
Study Director
Facility Information:
Facility Name
Center for the Treatment and Study of Anxiety, University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Facility Name
Carl R. Darnall Army Medical Center
City
Killeen
State/Province
Texas
ZIP/Postal Code
76544
Country
United States
Facility Name
University of Texas Health Science Center at San Antonio
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
32246153
Citation
Taylor DJ, Pruiksma KE, Hale W, McLean CP, Zandberg LJ, Brown L, Mintz J, Young-McCaughan S, Peterson AL, Yarvis JS, Dondanville KA, Litz BT, Roache J, Foa EB. Sleep problems in active duty military personnel seeking treatment for posttraumatic stress disorder: presence, change, and impact on outcomes. Sleep. 2020 Oct 13;43(10):zsaa065. doi: 10.1093/sleep/zsaa065.
Results Reference
derived
PubMed Identifier
31176888
Citation
Brown LA, Zang Y, Benhamou K, Taylor DJ, Bryan CJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Pruiksma KE, Fina BA, Young-McCaughan S, Peterson AL, Foa EB; STRONG STAR Consortium. Mediation of suicide ideation in prolonged exposure therapy for posttraumatic stress disorder. Behav Res Ther. 2019 Aug;119:103409. doi: 10.1016/j.brat.2019.103409. Epub 2019 May 23.
Results Reference
derived
PubMed Identifier
29362795
Citation
Foa EB, McLean CP, Zang Y, Rosenfield D, Yadin E, Yarvis JS, Mintz J, Young-McCaughan S, Borah EV, Dondanville KA, Fina BA, Hall-Clark BN, Lichner T, Litz BT, Roache J, Wright EC, Peterson AL; STRONG STAR Consortium. Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial. JAMA. 2018 Jan 23;319(4):354-364. doi: 10.1001/jama.2017.21242. Erratum In: JAMA. 2018 Aug 21;320(7):724.
Results Reference
derived
Links:
URL
https://delta.uthscsa.edu/strongstar/
Description
Link to Strong Star research consortium
Learn more about this trial
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
We'll reach out to this number within 24 hrs